Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Queensland Health
Baxter
Medtronic
Colorcon
Healthtrust
Johnson and Johnson
Julphar
Covington

Generated: May 23, 2018

DrugPatentWatch Database Preview

Jubilant Cadista Company Profile

« Back to Dashboard

What is the competitive landscape for JUBILANT CADISTA, and what generic and branded alternatives to JUBILANT CADISTA drugs are available?

JUBILANT CADISTA has nineteen approved drugs.



Summary for Jubilant Cadista
US Patents:0
Tradenames:17
Ingredients:16
NDAs:19
Patent Litigation for Jubilant Cadista: See patent lawsuits for Jubilant Cadista

Drugs and US Patents for Jubilant Cadista

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Cadista RISPERIDONE risperidone TABLET;ORAL 078828-004 Mar 23, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Jubilant Cadista ALENDRONATE SODIUM alendronate sodium TABLET;ORAL 090557-004 Feb 18, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Jubilant Cadista OXCARBAZEPINE oxcarbazepine TABLET;ORAL 090239-002 Jan 25, 2010 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Jubilant Cadista TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 075317-001 Dec 20, 2004 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Healthtrust
Farmers Insurance
Mallinckrodt
Moodys
Baxter
Citi
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.